Stay updated on BLU-5937 Efficacy and Safety in Refractory Cough Clinical Trial

Sign up to get notified when there's something new on the BLU-5937 Efficacy and Safety in Refractory Cough Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the BLU-5937 Efficacy and Safety in Refractory Cough Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The BLU-5937 Phase 3 chronic cough study record is displayed, with its status marked completed and no longer recruiting. It includes study design, eligibility and treatment details, outcome measures, and participating locations.
    Difference
    100%
    Check dated 2026-11-08T05:46:34.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.2 to v3.8.0 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T03:11:18.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces a transition from using “Artificial Intelligence” to “Super Intelligence” in federal agency content.
    Difference
    1%
    Check dated 2026-10-25T03:20:13.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2. The page continues to display a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-18T03:09:59.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T06:50:45.000Z thumbnail image
  7. Check
    43 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page now shows a 403 Forbidden message in place of the clinical study details.
    Difference
    17%
    Check dated 2026-10-04T03:55:26.000Z thumbnail image

Stay in the know with updates to BLU-5937 Efficacy and Safety in Refractory Cough Clinical Trial

Enter your email address, and we'll notify you when there's something new on the BLU-5937 Efficacy and Safety in Refractory Cough Clinical Trial page.